生化学工業株式会社 · Pharmaceutical · FY ends Mar
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | Kaisei Sha Co., Ltd. | 10,118,000 | 18.53% | ¥7.4B | ¥304M |
| 2 | Shin Gyo Co., Ltd. | 7,843,000 | 14.36% | ¥5.7B | ¥235M |
| 3 | 日本マスタートラスト信託銀行株式会社 | 4,114,000 | 7.53% | ¥3.0B | ¥123M |
| 4 | 株式会社日本カストディ銀行 | 1,347,000 | 2.47% | ¥982M | ¥40.4M |
| 5 | Kakenken Pharmaceutical Co., Ltd. | 1,207,000 | 2.21% | ¥880M | ¥36.2M |
| 6 | Seigo Naito | 1,141,000 | 2.09% | ¥831M | ¥34.2M |
| 7 | STATE STREET BANK AND TRUST COMPANY 505103 | 913,000 | 1.67% | ¥665M | ¥27.4M |
| 8 | 公益財団法人水谷糖質科学振興財団 | 828,000 | 1.52% | ¥603M | ¥24.8M |
| 9 | 明治安田生命保険相互会社 | 688,000 | 1.26% | ¥501M | ¥20.6M |
| 10 | ハイアール株式会社 | 630,000 | 1.15% | ¥459M | ¥18.9M |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| Takeshi Mizutani | President & Representative Director | 483,282 | ¥352M | — |
| 岡田 敏行 | Director | 27,774 | ¥20.2M | — |
| 船越 洋祐 | Director | 28,374 | ¥20.7M | — |
| 南木 みお | Director | 5,000 | ¥3.6M | — |
| 杉浦 康之 | Director | 4,500 | ¥3.3M | — |
| 鳥居 美香子 | Full-time Audit & Supervisory Board Member | 14,059 | ¥10.2M | — |
| 林 秀樹 | Full-time Audit & Supervisory Board Member | — | — | — |
| 松尾 信吉 | Audit & Supervisory Board Member | — | — | — |
| 丸山 貴之 | Audit & Supervisory Board Member | — | — | — |
| 三谷 和歌子 | Audit & Supervisory Board Member | — | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Mar 2026 | ¥729 | ¥26.99 | 27.0x | ¥30.0 | 56,814,000 |
| FY ending Mar 2025 | ¥739 | ¥22.25 | 33.2x | ¥30.0 | 56,814,000 |
| FY ending Mar 2024 | ¥766 | ¥40.08 | 19.1x | ¥26.0 | 56,814,000 |
| FY ending Mar 2023 | ¥814 | ¥40.49 | 20.1x | ¥26.0 | 56,814,000 |
| FY ending Mar 2022 | ¥875 | ¥66.32 | 13.2x | ¥30.0 | 56,814,000 |
| FY ending Mar 2021 | ¥1,035 | ¥75.54 | 13.7x | ¥24.0 | 56,814,000 |
| FY ending Mar 2020 | — | ¥-192.15 | — | ¥26.0 | 56,814,000 |
| FY ending Mar 2019 | ¥1,201 | ¥39.76 | 30.2x | ¥26.0 | 56,814,000 |
| FY ending Mar 2018 | ¥1,940 | ¥69.30 | 28.0x | ¥26.0 | 56,814,000 |